WebMD: Science Reveals 4 New Ways to Lower Your Dementia Risk
May 8, 2025
Sudha Seshadri, MD, professor and founding director of the Glenn Biggs Institute for Alzheimer’s and Neurogenerative Diseases, was quoted in this article. Read More
The Medicine Maker: Oral Alternatives for Injectable IV Medicines
May 7, 2025
Hong-yu Li, PhD, Department of Pharmacology and the Sam and Ann Barshop Institute for Longevity and Aging Studies, was quoted in this article. Read More
Engineering News-Record: $100M Brain Health Hub Rises on Tight Site in San Antonio
April 30, 2025
Sudha Seshadri, MD, professor and founding director of the Glenn Biggs Institute for Alzheimer’s and Neurogenerative Diseases, and Michael Charlton, PhD, senior vice president of Facilities and Capital Planning and chief facility planning officer, were interviewed for this article. Read More
Aging reimagined: Study finds immune resilience counters key drivers of disease, mortality
April 23, 2025
Robust immune systems may offer up to 15.5-year survival advantage What if, rather than focusing solely on the drivers of disease (pathogenesis), we also explored the factors sustaining our health — the concept of salutogenesis (derived from Salus (health) in Roman mythology)? The idea of salutogenesis through immune resilience, which refers to mechanisms by which the body counters disease drivers, could play […]
ScienceDaily: IV medication could be taken orally for range of cancer, Alzheimer’s treatments
April 22, 2025
Hong-yu Li, PhD, professor, Department of Pharmacology and the Sam and Ann Barshop Institute for Longevity and Aging Studies, and Robert A. Hromas, MD, FACP, dean of the Joe R. and Teresa Lozano Long School of Medicine, were quoted in this article. Read More
Mirage News — UT Health Breakthrough: IV Drugs May Go Oral
April 22, 2025
Hong-yu Li, PhD, professor, Department of Pharmacology and the Sam and Ann Barshop Institute for Longevity and Aging Studies, and Robert A. Hromas, MD, FACP, dean of the Joe R. and Teresa Lozano Long School of Medicine, were quoted in this article. Read More